Spilde Troy L, Bhatia Amina M, Marosky Julie K, Preuett Barry, Kobayashi Hiroyuki, Hembree Mark J, Prasadan Krishna, Daume Erica, Snyder Charles L, Gittes George K
Division of Pediatric Surgery, Childen's Mercy Hospital, Kansas City, Missouri 64108, USA.
J Pediatr Surg. 2003 Mar;38(3):474-7; discussion 474-7. doi: 10.1053/jpsu.2003.50082.
BACKGROUND/PURPOSE: The Adriamycin-induced rat model of esophageal atresia and tracheoesophageal fistula (EA/TEF) provides a reliable system for the study of EA/TEF pathogenesis. The authors previously hypothesized that faulty branching lung morphogenesis pathways were a critical component of its pathogenesis. The authors have found evidence for faulty fibroblast growth factor (FGF) signaling related to epithelial-mesenchymal interactions in the fistula tract. To better define FGF signaling, the differential expression of FGF ligands and their receptors between lung, fistula tract, and esophagus are described.
Time-dated pregnant, Sprague-Dawley rats were injected with Adriamycin (2 mg/kg intraperitoneally) on days 6 through 9 of gestation. Tissues were processed for histology and reverse transcriptase polymerase chain reaction. FGF-1, -7 and -10 were measured from whole lung, fistula tract, and esophagus of TEF or normal embryos. Expression of FGF2RIIIb and FGF2RIIIc receptors was measured in isolated epithelium and mesenchyme of lung and fistula tract of TEF embryos as well as lung and esophagus from normal controls.
FGF-1 mRNA was present in the fistula tract and normal and Adriamycin-exposed lung but absent from whole esophagus. Interestingly, FGF-7 mRNA was present only in normal lung. FGF-10 was present in all tissues examined. FGF2RIIIb mRNA was absent in fistula mesenchyme but present in all other tissues examined. However, the splice variant FGF2RIIIc mRNA was present in all tissues examined.
These findings support defective FGF signaling in the rat model of EA/TEF. Absence of FGF-7 mRNA in Adriamycin-exposed tissues suggests the primary effect of Adriamycin may be to inhibit FGF-7 expression. Moreover, absence of FGF2RIIIb in fistula mesenchyme may be caused by loss of positive feedback from FGF-7, its normal obligate ligand. Understanding these specific defects in FGF signaling may provide insight into faulty mechanisms of EA/TEF.
背景/目的:阿霉素诱导的大鼠食管闭锁合并气管食管瘘(EA/TEF)模型为研究EA/TEF发病机制提供了一个可靠的系统。作者之前推测,肺形态发生分支途径异常是其发病机制的关键组成部分。作者已发现与瘘管中上皮-间充质相互作用相关的成纤维细胞生长因子(FGF)信号传导异常的证据。为了更好地定义FGF信号传导,本文描述了FGF配体及其受体在肺、瘘管和食管之间的差异表达。
在妊娠第6至9天,给特定孕期的Sprague-Dawley大鼠腹腔注射阿霉素(2mg/kg)。对组织进行组织学处理和逆转录聚合酶链反应。从TEF或正常胚胎的全肺、瘘管和食管中检测FGF-1、-7和-10。在TEF胚胎的肺和瘘管以及正常对照的肺和食管的分离上皮和间充质中检测FGF2RIIIb和FGF2RIIIc受体的表达。
FGF-1 mRNA存在于瘘管以及正常和阿霉素处理的肺中,但在整个食管中不存在。有趣的是,FGF-7 mRNA仅存在于正常肺中。FGF-10存在于所有检测的组织中。FGF2RIIIb mRNA在瘘管间充质中不存在,但在所有其他检测组织中存在。然而,剪接变体FGF2RIIIc mRNA存在于所有检测的组织中。
这些发现支持EA/TEF大鼠模型中FGF信号传导缺陷。阿霉素处理的组织中缺乏FGF-7 mRNA表明阿霉素的主要作用可能是抑制FGF-7表达。此外,瘘管间充质中缺乏FGF2RIIIb可能是由于其正常的专一性配体FGF-7的正反馈缺失所致。了解FGF信号传导中的这些特定缺陷可能有助于深入了解EA/TEF的发病机制。